Singapore, 30 November 2011 ‐ Biosensors International Group, Ltd. (“Biosensors”, “Company”, Bloomberg: BIG SP) today announced Wellford Capital Limited, a wholly‐owned subsidiary of Weigao International Medical Co. Limited, which is in turn a wholly‐owned subsidiary of Shandong Weigao Group Medical Polymer Company Limited (“Shandong Weigao”) has fully exercised its rights in converting the US$120 million principal amount of 4% convertible notes due 2014 held in Biosensors.
As a result, Shandong Weigao will become the single largest shareholder of Biosensors with 370 million shares, or approximately 21.6% of the Company.
----------------
Createwealth8888:
due 2014. Why convert so early?
Morgan Stanley: US Dollar Has No Credible Challengers; Reserve Currency
Status to Endure – Economics Bitcoin News
-
The Chinese yuan, often considered a potential rival to the U.S. dollar,
currently falls short and is unlikely to dethrone the greenback. Read More
23 minutes ago
No comments:
Post a Comment